Improving the quality of cancer clinical trials : workshop summary / / National Cancer Policy Forum, Margie Patlack and Sharyl Nass, rapporteurs.
Saved in:
: | |
---|---|
TeilnehmendeR: | |
Year of Publication: | 2008 |
Language: | English |
Online Access: | |
Physical Description: | xii, 124 p. :; ill. (some col.). |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
LEADER | 02539nam a2200433 a 4500 | ||
---|---|---|---|
001 | 5003378368 | ||
003 | MiAaPQ | ||
005 | 20200520144314.0 | ||
006 | m o d | | ||
007 | cr cn||||||||| | ||
008 | 080709s2008 dcua sb 000 0 eng d | ||
010 | |z 2008299448 | ||
020 | |z 9780309116688 | ||
020 | |z 0309116686 | ||
035 | |a (MiAaPQ)5003378368 | ||
035 | |a (Au-PeEL)EBL3378368 | ||
035 | |a (CaPaEBR)ebr10235163 | ||
035 | |a (CaONFJC)MIL172680 | ||
035 | |a (OCoLC)923278949 | ||
040 | |a MiAaPQ |c MiAaPQ |d MiAaPQ | ||
043 | |a n-us--- | ||
050 | 4 | |a RC270.8 |b .I47 2008 | |
082 | 0 | 4 | |a 362.196/994007 |2 22 |
245 | 0 | 0 | |a Improving the quality of cancer clinical trials |h [electronic resource] : |b workshop summary / |c National Cancer Policy Forum, Margie Patlack and Sharyl Nass, rapporteurs. |
260 | |a Washington, D.C. : |b National Academies Press, |c c2008. | ||
300 | |a xii, 124 p. : |b ill. (some col.). | ||
504 | |a Includes bibliographical references. | ||
505 | 0 | |a Introduction -- New clinical trial designs. Phase 0 trials -- Adaptive trial designs -- Targeting multiple pathways with multiple drugs -- Preclinical model systems -- Molecular imaging. Current and developing methods -- Challenges of molecular imaging -- Screening for predictive markers. The challenges of clinical validation -- Bioimaging predictive markers -- Clinical translation -- Panel discussion -- Costs of clinical trials. Regulatory costs -- Patient accrual -- Global outsourcing -- Time is money -- Public-private collaborations -- Regulatory issues. Regulatory barriers to innovation -- Patient advocacy perspective -- Regulation of in vitro diagnostics -- Regulatory issues in improving cancer clinical trials -- Reports from the case study discussion groups. Adaptive trial design -- Phase 0 trials -- Imaging -- Use of proteomics/genomics to assign therapy in lung cancer -- Use of genetics/genomics to assign therapy. | |
530 | |a Also available on the World Wide Web. | ||
533 | |a Electronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries. | ||
650 | 0 | |a Cancer |x Treatment |z United States. | |
650 | 0 | |a Clinical trials. | |
655 | 4 | |a Electronic books. | |
700 | 1 | |a Patlak, Margie. | |
700 | 1 | |a Nass, Sharyl J. | |
710 | 2 | |a National Cancer Policy Forum (U.S.) | |
710 | 2 | |a Institute of Medicine (U.S.) | |
710 | 2 | |a ProQuest (Firm) | |
856 | 4 | 0 | |u https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=3378368 |z Click to View |